Head-to-head · Value Score
CoreAge Rx vs NativeMed
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, NativeMed a 72. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameNativeMed
#193 · Grade C · Watch List
Est. first month
From $149/mo (promotional rate, compounded)
Save ~89% vs brand-nameFDA warning letter. The FDA issued NativeMed LLC dba NativeMed a warning letter in June 2026. Check it on the FDA database.
Get this deal Full NativeMed review →The verdict
CoreAge Rx takes it on Value Score, 93 to 72 — an est. $99/mo first month, with no teaser step-up baked in. NativeMed isn't out of it: Someone comparing entry prices who will ask what the second month costs.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | NativeMed |
|---|---|---|
| Value Score | 93 (A+) | 72 (C) |
| Est. first month | $99/mo | From $149/mo (promotional rate, compounded) |
| Save vs brand-name | ~89% | ~89% |
| Semaglutide | $99/mo | From $149/mo (promotional rate, compounded) |
| Tirzepatide | $149/mo | From $183/mo (promotional rate, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
NativeMed
NativeMed, LLC is a Miami cash-pay telehealth service selling compounded semaglutide at $149 and tirzepatide at $183 as sale prices against listed regular rates of $299 and $399, with no membership fee.
Why it's a deal
- No membership fee on top of the medication, stated plainly on the storefront
- Both molecules priced openly rather than held until after an intake
- Names its operating entity, NativeMed LLC, with a stated Miami base
- Uses US-based pharmacies and says so, with no insurance required
The fine print
- Every price is a sale price against a regular rate twice as high, with a "Limited Time Offer" badge and no stated end date
- Pharmacy partners are described only as "USA-based" or "accredited" and never named
- The states served are not listed publicly
- GLP-1s sit beside generic sildenafil, tadalafil and trazodone, so this is a general storefront rather than a weight-loss specialist
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to NativeMed.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.